Post by Merz Therapeutics

We are pleased to share that Teijin Limited has received approval in Japan for additional indications in cervical dystonia and blepharospasm. This milestone marks an important step in expanding treatment options for people living with these conditions in Japan. Find out more here: https://lnkd.in/e55FzTeU #MerzTx #CompanyNews